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Abstract 
Adequate vascularization in biomaterials is essential for tissue regeneration and repair. Current 
models do not allow easy analysis of vascularization of implants in vivo, leaving it a highly desirable 
goal. A tool that allows to monitor the perfusion capacity of such biomaterials non-invasively in a 
cheap, efficient and reliable in vivo model would hence add great benefit to the research in this field. 
We established, for the first time, an in vivo Magnetic Resonance Imaging (MRI) method to quantify 
the perfusion capacity of a model biomaterial, DegraPol® foam scaffold, placed on the embryonic 
avian chorioallantoic membrane (CAM) in ovo. Perfusion capacity was assessed through changes in 
the longitudinal relaxation rate before and after injection of a paramagnetic MRI contrast agent, Gd-
DOTA (®Dotarem, Guerbet S.A.). Relaxation rate changes were compared in three different regions of 
the scaffold, i.e. at the interface to the CAM, in the middle and on the surface of the scaffold (p < 
0.05). The highest relaxation rate changes, and hence perfusion capacities, were measured in the 
interface region where the scaffold was attached to the CAM, whereas the surface of the scaffold 
showed the lowest relaxation rate changes. A strong positive correlation was obtained between 
relaxation rate changes and histologically determined vessel density (R2 = 0.983), which corroborates 
our MRI findings. As a proof-of-principle, we measured the perfusion capacity in different scaffold 
materials, silk fibroin either with or without human dental pulp stem cells. For these, 3 – 4 times 
larger perfusion capacities were obtained compared to DegraPol®; demonstrating that our method is 
sensitive to reveal such differences. 
In summary, we present a novel in vivo method for analyzing the perfusion capacity in 3D- 
biomaterials grown on the CAM, enabling the determination of the perfusion capacity of a large 
variety of bioengineered materials. 
 
Key words 
Chorioallantoic membrane (CAM), DegraPol®, perfusion capacity, vascularization, magnetic 
resonance imaging (MRI) 
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Introduction 
Tissue engineered constructs for regenerative medicine are based on scaffolds that are used as a 
matrix for cells to attach and proliferate, so that these artificial grafts can be implanted at defect 
sites. For this purpose they should provide a high level of biocompatibility. Moreover, vascularization 
is often required, i.e. the grafts should be easily vascularized after implantation and guarantee long-
term functionality and survival of the implanted material and cells. To sustain the artificial graft in an 
environment as a functional tissue, it is necessary that the blood vessels penetrate the porous grafts 
from the surrounding tissue since the transport of oxygen and nutrients is dependent on a 
homogenously distributed vascular network in the implanted scaffold (1-5).  
Artificial engineered grafts can have different effects on vascularization. Not only the pore size, but 
also the size of the scaffold and the interconnectivity of the pores are important criteria for blood-
vessel ingrowth after implantation (3, 4).  Numerous ex vivo and in vivo approaches have been 
established in order to monitor vascularization of tissue grafts including rodents, chicken and fish (6, 
7) . Ex vivo assays are rapid but more limited because of the lack of inflammation and metabolic 
processes that may affect the vascularization. Most of the currently available in vivo assays involve 
time, money, and repetitive animal sacrifice, and they are complex and sometimes not easy to 
compare (3, 8). The chorioallantoic membrane (CAM) of the chick embryo is a well-established model 
for studying vascularization in vitro and in vivo and is typically referred to as CAM assay (9, 10).  It is a 
very useful model because of the easy accessibility of the vascular network. Moreover, its lack of 
immune competence enables studies dealing with tumor growth, wound healing, angiogenesis, anti-
angiogenesis or biocompatibility of xenografts (3, 11, 12). In addition, the CAM provides an excellent 
environment where the cells can attach and proliferate in 3D scaffolds. Finally, the CAM assay is a 
rapid, simple and low-cost screening method for tissue reactions towards biomaterials (9).  
An increasing amount of literature highlights the as yet unmet need to non-invasively monitor the 
vascularization extent of the implanted scaffolds in order to analyze the success of tissue 
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regeneration in vivo (13, 14). To date, there are only few studies which use Magnetic Resonance 
Imaging (MRI) as a non-destructive, non-invasive method to study biomaterials on the CAM (9, 10). 
Our current work presents for the first time the application of MRI to measure the perfusion capacity 
of CAM-implanted scaffolds in situ on the CAM in the living chicken embryo. This method allows a 
continuous, longitudinal monitoring of developing vessels and hence perfusion capacity in 
biomaterials in vivo. 
The particular objectives of our study were (i) to quantify the perfusion capacity within a model 
scaffold biomaterial, DegraPol® foam, implanted for 7 days on the CAM by MRI in ovo and in vivo as a 
function of local distance from the CAM and as a function of time after contrast agent injection,(ii) to 
correlate our MRI findings with histological analyses of vessel density, and (iii) to apply the 
established method as a proof-of-principle to different biomaterials discovering the impact of human 
dental pulp stem cells (hDPSCs) on the perfusion capacity of a silk fibroin scaffold. In sum, we present 
a new and low cost screening method to study angiogenesis-related questions in the field of tissue-
engineered biomaterials. 
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Materials and Methods 
Scaffolds 
DegraPol®: The synthetic polyester-urethane DegraPol® is a biocompatible and biodegradable 
material based on poly-hydroxy-butyrate as a crystalline segment and -caprolactone as a soft 
segment (15). Originally, its synthesis aimed at generating a suitable scaffold material for bone tissue 
engineering (16), but has recently also been shown to be a beneficial scaffold material for cartilage 
(17), nerves (18) and tendons (19).  
DegraPol® foams were kindly provided by ab medica, Italy. They were soaked in cyclohexane (Fluka, 
puriss.) and frozen at -20°C overnight. They were cut into equal pieces of 8 x 4 x 3 mm3 immediately 
after removal from the freezer and were dried at room temperature (evaporation of cyclohexane). 
All foams were sterilized with ethylenoxide before placing them carefully on the chorioallantoic 
membrane. 
Silk fibroin: Silk fibroin is a biocompatible (after the removal of sericin) and biodegradable material 
whose physical and mechanical properties can be easily manipulated through structural 
readjustments(20, 21). It is derived from silkworm cocoons of Bombyx mori, which contains at least 
two major fibroin proteins, light and heavy chains, 25 and 325 kDa, respectively(22). Due to its 
versatility it has become a popular biomaterial for various applications, e.g. in bone tissue 
engineering(20). Silk fibroin scaffolds (Trudel Silk Inc., Zurich, Switzerland) with a diameter of 5 mm, a 
height of 3 mm and a pore size of 200 – 300 µm were used.  They were prewetted for 36 h in 
phosphate buffered solution to rehydrate them before use. After autoclaving (121 °C, 1 bar, 20 min) 
scaffolds were immersed either in a cell-suspension (0.5 x 106 cells/ scaffold) or in cell-free culture 
medium, respectively. As culture medium, DMEM/F12 (Sigma, D8437) with 10 % FBS (PAN Biotech 
GmbH, 2602-P291705), 1 % Pen/Strep (Sigma, P0781), 1 % L-Glutamine (Sigma, G7513) and 0.02 % 
fungizone (Invitrogen, 15290-018) was used. Cell-seeded and cell-free scaffolds were placed in the 
incubator (37 °C, 5 % CO2) to allow attachment of the cells. After 1 h scaffolds were washed in fresh 
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culture medium and placed into a 24-well-plate with 0.8 mL of culture medium in the incubator 
overnight. After that the scaffolds were placed on the CAM of the fertilized chicken eggs. 
Cells 
HDPSCs were obtained from dental pulps of healthy teeth of adult patients after the extraction of 
impacted wisdom teeth. The procedure was approved by the Kantonale Ethikkommission of Zurich 
(reference number 2012-0588) and performed with written patients’ consent. After the removal of 
the dental pulp from the tooth, hDPSCs were isolated, expanded and characterized as described 
previously(23). 
CAM assay 
Fertilized Lowman white LSL chick eggs (Animalco AG Geflügelzucht, Staufen, Switzerland) were 
incubated at 37°C and 65% relative humidity. On incubation day (ID) 3.5 a circular window with a 
diameter of 40 - 45 mm was drilled into the eggshell after removing 2 mL albumen so that the 
developing chorioallantoic membrane detached from the eggshell.  The window in the eggshell was 
closed with a sterile Petri dish of 50 mm to prevent dehydration. On ID 7, DegraPol® foam scaffolds, 
cell-seeded silk fibroin scaffolds and cell-free silk fibroin scaffolds were carefully placed on top of the 
chorioallantoic membrane, one scaffold into each egg. The scaffolds were put in the middle of 1 cm-
diameter plastic rings to flatten the surface of CAM (Figure 1). Afterwards the eggs were incubated 
for another 7 days until ID 14.  
In vivo assessment of perfusion capacity using MRI  
On ID 14, vascularization of the scaffold by capillaries of the chick embryo’s chorioallantoic 
membrane was studied in situ on the CAM (“in ovo”) of the living chicken embryo (“in vivo”) using 
Magnetic Resonance Imaging (MRI) in 8 samples. For the MRI examination, the eggs were placed 
onto a custom-built sliding bed and enveloped by warm water tubing to maintain the temperature of 
the chick embryo in a physiological range. To prevent motion of the chick embryos, they were 
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sedated with 5 drops of 1:100 M ketamine (Ketasol-100, Graeub, Switzerland) dripped onto the CAM 
surface.  
MRI was performed with a 4.7 T/16 cm Bruker PharmaScan small animal scanner (Bruker BioSpin, 
Ettlingen, Germany) equipped with an actively decoupled two-coil system consisting of a 72 mm bird 
cage resonator for excitation and a 20 mm single loop surface coil for reception. The surface coil was 
fixed on the Petri dish that covered the eggshell window directly above the scaffold for optimal 
sensitivity.  
Anatomical reference images were obtained in coronal, transversal and sagittal slice orientations 
(FLASH sequence, TR/TE 200/3 ms, image matrix size 128 x 128, field of view 60 x 60 mm2, 5 slices, 
images reconstructed to a nominal resolution of 0.23 x 0.23 x 1 mm3, total scan time 25 s). T1-
weighted MR images were acquired with a RARE sequence of variable TR and TE for quantitative T1 
and T2 mapping (TR 200/400/800/1500/3000/4500ms, TE 10/30/50/70/90ms, RARE-factor 2, image 
matrix size 220 x 150, field of view 45 x 30 mm2, spatial resolution 0.2 x 0.2 mm2, slice thickness 1 
mm, total scan time 9 min 40 s).  
T1 maps were acquired in 8 DegraPol®, 4 silk fibroin and 4 silk fibroin samples seeded with hDPSCs 
before and after i.v. injection 100 µL 0.05 M Gd-DOTA MRI contrast agent (Dotarem®, Guerbet S.A., 
Switzerland). The time between Gd-DOTA injection and T1 mapping was held constant at 25 min. An 
additional time series was acquired in 3 DegraPol®samples with T1 map acquired at 15, 25, 35, 45 and 
60 min post-injection.  
T1 relaxation times were determined in three regions of interest at (i) the surface of the scaffold, (ii) 
in the middle, and (iii) at the interface of the scaffold with the CAM. Perfusion capacity in these three 
regions of interest was assessed through changes in the longitudinal relaxation rate, ∆R1=R1-R10, 
before and after injection of Gd-DOTA, as the relaxation rate changes with the amount of gadolinium 
present in the CAM: 
R1 = R10 + r1 ∙ [Gd] 
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where  
R1 = 1/ T1  
are the longitudinal relaxation rate after and R10 before contrast agent administration and r1 the 
molar relaxivity of the contrast agent in s-1 mol-1 L and [Gd] the concentration of Gd in mol L-1. 
Intravenous injection of Gd-DOTA 
For intravenous injection of the MRI contrast agent, eggs were placed on a 37 °C heating bed and i.v. 
injection was performed under a surgical microscope with 12 – 20 x magnification. A big and straight 
vein on the surface was selected and grasped by a microsurgical forceps and 100 µL Gd-DOTA slowly 
injected with a 1.0 mL syringe and 30G needle. A cotton sticker was placed on the injection site of the 
vessel with slight pressure before the syringe was withdrawn to prevent bleeding.   
Histological analyses 
After completion of the MRI measurements the scaffold-CAM complex was fixed overnight using 4 % 
formalin solution in PBS, then excised, embedded in paraffin, cross-sectioned in 5 µm slices and  
stained with H&E, CD31 (PECAM-1 (M-20): sc-1506, Santa Cruz Biotechnology; staining procedure for 
paraffin sections of the VECTASTAIN Elite ABC Kit-Rabbit IgG (PK-6101; VECTOR LABORATORIES, INC., 
Burlingame, CA, USA)) and Von Willebrand Faktor (Factor VIII) (Dako) according to established 
procedures (24). Slices were obtained from three regions of the scaffold: (i) surface, (ii) middle, and 
(iii) interface to the CAM, and 3 - 4 slices for each region were analyzed. The vessel density was 
scored semi-quantitatively by counting the number of vessels manually under a light microscope 
(Leica DM 6000 B, Zurich, Switzerland) equipped with a digital camera; with 0 = no vessels, 1 = < 10, 
1.5= 10 - 30, 2 = 30 - 50, 2.5 = 50 - 70, 3 = 70 - 90, 3.5 = 90 - 110, 4 = 110 – 130, 4.5 = 130-150 and 5 = 
> 150 vessels in a cross-section of 32 mm2. 
Statistics 
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The correlation of capillarity densities and the change in relaxation rates, ΔR1, was determined by 
linear regression using StatView 5.0.1. Moreover, one-way analysis of variance (ANOVA) was 
conducted. Pairwise comparison probabilities (p) were calculated using the Fisher’s PLSD. P values < 
0.05 were considered significant.    
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Results 
MRI measurements 
The ability to quantify the perfusion capacity is crucial for assessing the biocompatibility of tissue-
engineered grafts and biomaterials. Here, we used MRI to assess perfusion capacity through changes 
in the R1 relaxation rates, ∆R1, before and after injection of a paramagnetic MRI contrast agent, Gd-
DOTA. In Figure 2, T1-weighed images before and after injection are depicted. In the pre-contrast 
image, the scaffold and supportive plastic ring and head of the chick embryo can be distinguished, 
but are much better delineated in the post-contrast image, as the scaffold and embryonic structures 
show high contrast enhancement, while the adjacent tissue shows little uptake. As for the scaffold 
material implanted on the CAM, it is shown that contrast enhancement varies locally within the 
scaffold and that the largest signal change appears at the interface to the CAM (see enlarged section 
that zooms into the scaffold). Noteworthy to mention is the clear border of the contrast agent 
uptake at the interface to the CAM. While little Gd-DOTA uptake is found next to the scaffold 
implying little vascularization, there is a high contrast agent uptake at the interface. A quantitative 
analysis is summarized in Figure 3, which shows that the relaxation rate change, ∆R1, and hence 
perfusion capacity, declines from interface to the CAM towards the surface region of the scaffold (n = 
8).  
Finally, the relaxation rate change, ∆R1, was monitored as a function of time after injection of Gd-
DOTA (n = 3). As shown in Figure 4, the signal intensity reached a plateau at 35 min in all regions of 
interest studied. 
Histology  
Quantification of vessel density was accomplished by counting the number of blood vessels within 
cross-sections of 8 mm x 4 mm stained by H&E (Figure 5a). Vessels were identified as roundish blue 
structures lining endothelial cells. Representative images for each score level are available as 
supplementary material to this paper (Supplementary Information SI Figure 1). Vessel counts from 
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H&E staining were also confirmed by an additional scoring in von Willebrand Factor immunostained 
corresponding sections (Figure 5b). In addition, CD31 staining revealed the same vessel counts as 
determined by H&E and von Willebrand Factor stainings (Figure 5c). These histological analyses 
revealed that the interface region of the implanted DegraPol® scaffold with the CAM showed the 
highest number of small blood vessels compared to middle and surface, with an average vessel 
density score of 3.05 ± 1.34; 2.42 ± 1.15 and 1.47 ± 0.65, respectively. The surface region with the 
longest distance to the CAM had the lowest number of small blood vessels (Figure 6). Therefore, the 
same regional pattern of vascularization was observed as in our MRI data. Furthermore,  a strong 
correlation was obtained between relaxation rate changes, ∆R1, and the histological scores for vessel 
density (R2= 0.983). Thus, the histology data corroborate the MRI findings. 
Perfusion capacity in different biomaterials (Proof-of-principle) 
In order to apply the method to other biomaterials than DegraPol®, relaxation rate changes, ∆R1, of 
silk fibroin scaffolds (± hDPSCs) were measured for the same corresponding scaffold regions 
(interface, middle and surface, Figure 3). For all three regions, the perfusion capacity of silk fibroin 
scaffolds was significantly higher compared to the DegraPol® scaffolds (3 - 4 times higher, p < 
0.0001). However, the hDPSCs did not evoke a statistically significant higher perfusion of the silk 
fibroin scaffolds compared to the cell-free silk fibroin scaffolds (p > 0.1). Only a trend was noticed for 
all three regions, where the perfusion was higher in the presence of the hDPSCs compared to the 
cell-free scaffolds. CD31 staining clearly showed the vessels inside the silk fibroin scaffold seeded by 
hDPSCs (Figure 5d). Finally, in both biomaterials, DegraPol® as well as silk fibroin (± hDPSCs), 
perfusion capacity declines from the interface towards the surface, in line with the scaffolds being 
vascularized from the CAM towards the surface.   
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Discussion 
In the current study, we present for the first time a cheap screening method for non-invasive 
quantification of the perfusion capacity of biomaterials with MRI in vivo. We found a strong positive 
correlation between local changes in T1- based relaxation rates in biomaterials grown 1 week on the 
chorioallantoic membrane (CAM) and the vessel density determined by histology.  
Vascularization in three-dimensional biomaterials is a limiting factor for successful implantation and 
functionalization of these engineered tissues. The highly vascularized CAM of the chick embryo is a 
useful model to evaluate the tissue response and perfusion capacity of scaffolds placed on top of the 
CAM. Furthermore, this avian model provides a good nutritional environment to tissue-engineered 
materials. Compared to the traditional mammalian models, the CAM assay is cheap, more time 
efficient and does not have any immune-system based reaction towards foreign bodies (6). Thus, it 
allows – among many other applications - to work with human tumor cells in order to study tumor-
induced angiogenesis (25) or chemoprevention (26). Even in environmental pollution and health 
debates, it may serve as a valuable model (27). Finally, the CAM assay has been well established (6), 
is low priced and predominantly used to study angiogenesis and anti-angiogenesis in response to 
different drugs, growth factors and cell types (3, 28). 
As a model biomaterial, we chose a biodegradable DegraPol® foam because this polyester-urethane 
has been shown to be biocompatible with respect to osteoblasts (16), chondrocytes (17) and 
tenocytes(29) among others. To date, many studies examined the tissue response towards 
biomaterials using the CAM model (3, 8), or tested different biomaterials such as PVC or modified 
polyurethanes with respect to angiogenesis and inflammatory response (30).However,  they often 
use “end-point” information such as histological analysis which necessitates the destruction of the 
tissue-engineered construct. In a previous study we therefore presented MRI as a non-destructive, 
analytical tool for studying vascularization ex vivo  in the same biomaterial grown on the CAM (10). 
While MRI has been employed in vivo to determine the mineralization of bone constructs placed on 
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the CAM (9), it has not been used so far for the assessment of the perfusion capacity. Our present 
study therefore shows for the first time MRI as a suitable method to examine the perfusion capacity 
in biomaterials placed on the CAM in situ in the living chicken embryo. The combination of the CAM 
model with an in ovo and in vivo MRI readout offers the potential to longitudinally monitor the 
perfusion capacity of biomaterials. In other words, the vascularization process can be followed in vivo 
by non-invasive MRI, thereby offering a novel screening method to quantify the perfusion capacity of 
a series of different biomaterials at different time points in the same sample. 
In particular, our data show that the perfusion capacity of scaffolds grown for one week on the CAM 
can be quantified by analyzing relaxation rate changes, as these are dependent on the amount of 
contrast agent present in the vascular network. Inspection of contrast-enhancement within the 
scaffold revealed regional variations and a region of interest analysis of relaxation rate changes was 
performed to assess such heterogeneity more quantitatively. As such, perfusion capacity was found 
to be highest at the interface where the scaffold was attached to the CAM while it gradually 
decreased with distance from the interface with lowest perfusion capacity found at the surface of the 
scaffold. Presumably, DegraPol® scaffolds were too large to be fully vascularized as has been found 
for smaller DegraPol® foams (30 mm3 as compared to 96 mm3 used here) in our previous study (10). 
Semi-quantitative histological analyses of vessel density in locally staggered histological sections 
taken from the interface, middle and surface of the scaffold corroborates the MRI findings as the 
highest vessel density was found at the interface and lowest at the surface of the scaffold. 
Furthermore, histological scores were found to strongly correlate with the relaxation rate changes, 
providing further support for our notion that relaxation rate changes may be used as a simplified 
measure for perfusion capacity. 
In order to apply this newly established method to a typical question in the field of tissue engineering 
(as a proof-of-principle), silk fibroin scaffolds either with or without hDPSCs were also analyzed with 
respect to their perfusion capacity by MRI. First of all, the differences in the relaxation rates between 
the two materials DegraPol® and silk fibroin were significant; silk fibroin showed 3 - 4 times higher 
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relaxation rates compared to DegraPol®, which renders silk fibroin a much better scaffold material in 
terms of a fast vascularization. Secondly, silk fibroin seeded with hDPSCs had higher relaxation rates 
compared to cell-free constructs (trend), implying that an in vitro preseeding of only one day (!) has 
already a beneficial impact on the perfusion extent in ovo. The hDPSCs are involved in the building of 
new vessels inside the silk fibroin as confirmed by histological analysis of typical endothelial cell 
markers (von Willebrand Factor and CD31). Therefore, our method leads to remarkable changes in 
R1 for different scaffold materials as well as it is sensitive already for minor changes in preparation 
such as a 1-day preseeding by stem cells. 
Some limitations of the in ovo CAM model as used in our study should be mentioned, however. First, 
only 30 – 40 % of the windowed eggs survived the opening of the eggshell. This may mostly be 
attributed to eggshell dust contaminating the otherwise sterile egg cavity and its environment during 
windowing. Smaller windows might reduce the risk of contamination, however, larger windows allow 
minimizing the distance between the scaffold and the surface coil during MRI measurements and 
facilitate access to the vasculature during contrast agent injection, which is necessary for higher 
resolutions. Second, the injection of the contrast agent was a highly delicate process due to the small 
vessel size and flexibility within the egg yolk. An experienced microsurgeon (Y.T.) provided the 
required skills, but these can be also acquired by others through dedicated trainingThird, there is a 
limitation in size of the biomaterial under investigation; a size of 8 x 4 x 3 mm3 as used in case of the 
DegraPol® scaffolds could have a bigger area placed on the CAM, however, the height (3 mm) cannot 
be increased much because during a time frame of 7 days, vessel growth starting from the CAM 
surface might not reach the top of the scaffold. Moreover, the timing between contrast agent 
injection and relaxation time measurement was set at 25 min. This time window was considered 
ample for the contrast agent to distribute in the microvasculature and extravascular compartment 
and the relaxation rate change, and hence perfusion signal, being not dominated by wash-in effects 
of bigger vessels. In order to assess possible effects of this specific time window we acquired a time 
series of relaxation rate changes between 15 - 60 min post-injection in 3 samples. These data reveal 
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that contrast agent uptake is highest 35 min post-injection, indicating that other processes, such as 
diffusion, also contribute to the rather slow contrast agent uptake (31). Thus, for highest contrast our 
preset time window of 25 min post-injection, which was preset such as to maximize uptake of 
contrast agent but also aimed at reducing necessary scantime, will be increased in future studies. 
 Finally it should be mentioned that in our study we did not take full advantage of our method’s 
potential to perform longitudinal measurements that our in ovo CAM model combined with non-
invasive in vivo MRI readout offers. In order to do so, a couple of legal, physiological and technical 
issues will need to be tackled: Experimental procedures with fertilized eggs fall under the legislation 
of the Swiss federal ordinance on animal protection and welfare starting on ID 14 and hence the 
prerequisite legal framework needs to be set into place for experiments lasting longer than ID 14. On 
the physiological side it remains to be established how much the development of the vascular 
network and ultimately perfusion capacity is affected by stress induced by the handling of the egg, 
anesthesia, MRI measurement and contrast agent injection. Previous studies indicate that such 
effects exist and warrant further investigation (32). And finally, contrast agent doses might need to 
be titrated down such as to enable repeated measurements, in particular as renal clearing rates in 
the avian embryo are not known and the contrast agent supposedly remains in the closed 
environment of the egg. 
Nevertheless, the method established here is really beneficial for tissue engineering and 
regeneration purposes because it allows performing a cheap and fast in vivo screening of the 
perfusion extent of any biomaterials or bio-artificial constructs. It hence allows gathering valuable 
preclinical information about a material’s potential long-term functionality and survival in the host 
tissue and therefore may steer early candidate selection for further development.  Furthermore, for 
the benefit of the 3 R’s, it has become mandatory to evaluate cell-scaffold constructs prior to in vivo 
experiments (33). With a cost of only 2 dollars per egg it is much cheaper compared to animal models 
such as mice (> 25 dollars), rats (> 35 dollars) or rabbits (> 200 dollars). Moreover, vascularization of 
the biomaterials can be monitored as a function of time with non- invasive MRI and valuable 
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information can be gathered within a time frame of only two weeks including one week of incubation 
and one week of monitoring angiogenesis in the material under view. 
In sum, the CAM model’s cost effectiveness and the absence of immune-defense reactions combined 
with the non-invasiveness of MRI to access the perfusion capacity of biomaterials and tissue 
engineered constructs in vivo and in ovo will increase the attractiveness of this distinguished 
combination in the future. We conclude that the CAM assay together with non-invasive MRI presents 
a reliable in vivo model for monitoring the perfusion capacity of biomaterials. Further studies are 
planned with arrays of different biomaterials and differently pre-engineered biomaterials in our 
laboratory. 
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Figure Captions 
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Figure 1. DegraPol® foam scaffold (arrow) placed in the middle of a supportive plastic ring on top of 
the CAM on ID 7.   
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Figure 2.  In ovo T1-weighted MRI images acquired 7 days post-implantation in an axial slice through 
the scaffold. (a) before, (b) 25 min after i.v. injection of Gd-DOTA. Enlarged section: scaffold with 
regions of interest (circles) at the interface with the CAM, in the middle and on the surface of the 
scaffold. 
  
 Page 23 of 51 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
C:
 M
et
ho
ds
A
 n
ew
 in
 v
iv
o 
M
RI
 m
et
ho
d 
to
 n
on
-in
va
siv
el
y 
m
on
ito
r a
nd
 q
ua
nt
ify
 th
e 
pe
rfu
sio
n 
ca
pa
ci
ty
 o
f 3
D
-b
io
m
at
er
ia
ls 
gr
ow
n 
on
 th
e 
ch
or
io
al
la
nt
oi
c 
m
em
br
an
e 
of
 c
hi
ck
 e
m
br
yo
s (
do
i: 1
0.1
08
9/t
en
.T
EC
.20
14
.02
12
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
24 
24 
 
 
 
Figure 3. Relaxation rate change ∆R1 in three regions of interest at the interface, middle and surface 
of the DegraPol® and silk fibroin scaffolds either with or without human dental pulp stem cells grown 
for 1 week on the CAM. Values are given as means ± standard deviation. P-values are denoted as * is 
p < 0.05; ** p < 0.01 and *** p < 0.001. Asterisks without line refer to comparisons to DegraPol®. 
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Figure 4. Relaxation rate change ∆R1 as a function of time after contrast agent injection in three 
regions of interest at the interface, middle and surface of the DegraPol® scaffold. Values are given as 
means ± standard deviation. 
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Figure 5. Histological cross sections showing the capillaries in the scaffold material: (a) H&E staining 
of DegraPol® at 100 x magnification; (b) immunostaining with von Willebrand Factor of DegraPol® at 
200 x magnification; (c) immunostaining with CD31 of DegraPol® at 630 x magnification 
(counterstaining Toluidine Blue) and (d) immunostaining with CD31 of silk fibroin seeded with 
hDPSCs (counterstaining hematoxylin) at 400 x magnification. A few vessels are exemplarily 
highlighted by arrows. 
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Figure 6. Relaxation rate change ∆R1 as a measure of perfusion capacity versus vessel density 
obtained by semi-quantitative scoring of histological slices in three regions of interest at the 
interface, middle and surface of the scaffold-CAM complex. Relaxation rate change and vessel 
density in the scaffold are highest at the interface to the CAM and decrease with distance from the 
CAM. Scores  1 = < 10, 1.5= 10 - 30, 2 = 30 - 50, 2.5 = 50 - 70, 3 = 70 - 90, 3.5 = 90 - 110, 4 = 110 – 130, 
4.5 = 130 - 150 and 5 = > 150 vessels counted in a cross-section of 32 mm2. Values are given as means 
± standard deviation. P-values are denoted as (*) is p < 0.1; * p < 0.05 and ** p < 0.01. 
Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
  
 Page 48 of 51
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
C:
 M
et
ho
ds
A
 n
ew
 in
 v
iv
o 
M
RI
 m
et
ho
d 
to
 n
on
-in
va
siv
el
y 
m
on
ito
r a
nd
 q
ua
nt
ify
 th
e 
pe
rfu
sio
n 
ca
pa
ci
ty
 o
f 3
D
-b
io
m
at
er
ia
ls 
gr
ow
n 
on
 th
e 
ch
or
io
al
la
nt
oi
c 
m
em
br
an
e 
of
 c
hi
ck
 e
m
br
yo
s (
do
i: 1
0.1
08
9/t
en
.T
EC
.20
14
.02
12
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
49 
49 
 
 
Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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Supplementary Information Figure 1. Typical images of H&E stained sections showing examples of 
scoring levels with a range from 1 to 5: 1 = < 10, 2 = 30 - 50, 3 = 70 - 90, 4 = 110 - 130 and 5 = > 150 
vessels counted in a cross-section of 32 mm2. 
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